| |
| Official Contact Inforamtion |
|
Institution:
|
University of Connecticut Health Center
|
|
Department Name:
|
Department of Genetics and Developmental Biology
|
|
Position
:
|
Instructor in Basic Research
|
|
Street And Number
:
|
263 Farmington Avenue
,
Farmington, CT. MC3301
,
United States
|
|
Official Phone
,
Official Fax
:
|
(860) 679 2461
,
(860) 679 8345
|
|
E-mail
|
ikalaj@neuron.uchc.edu
|
|
Web
|
|
|
| |
clinical chemistry and laboratory medicine (fundamental medical sciences.Biomedicine and Public Health)
|
| Education |
|
1996
|
M.D.
Zagreb University School of Medicine
,
Zagreb
,
Hrvatska (Croatia)
|
| Employment Positions |
|
2002
|
Instructor
Department of Genetics and Developmental Biology,
University of Connecticut Health Center, Farmington, CT
,
Farmington
,
United States
|
|
2000 - 2002
|
Postdoctoral fellow
Department of Genetics and Developmental Biology
University of Connecticut Health Center, Farmington, CT.
,
Farmington
,
United States
|
|
1997 - 2000
|
Postdoctoral fellow
Department of Pediatrics
University of Connecticut Health Center, Farmington, CT.
,
Farmington
,
United States
|
|
1996 - 1997
|
Intern
University Hospital Split,
,
Split
,
Hrvatska (Croatia)
|
| Academic Positions |
| Teaching |
| Guest teacher |
| Congres |
|
2003
|
The Osteoblast Lineage in The OIM Model. Conference: New Research Strategies in Osteogenesis Imperfecta
,
Hospital for Special Surgery. New York
,
,
New York
,
United States
|
|
2002
|
Use of Col1a1 Transgenic To Identify Populations of Cells Within the Ostaoblast Lineage
,
Dept. of Orthopedics, Creighton University, Omaha.
,
,
Omaha
,
|
|
2000
|
Dept. of Research, Saint Francis Hospital, Hartford, CT
,
Use of Promoter-Transgenes Mice To Identify Stages Within the Ostaoblast Lineage.
,
,
Hartford
,
United States
|
|
1999
|
7th International Conference on osteogenesis imperfecta, Montreal,
,
Osteoblastic activity in the OIM mouse
,
,
Montreal,
,
Canada
|
| Projects |
|
2004 - 2005
|
PI: Kalajzic, I.
Title: “Calcifying Cells in the Atherosclerostic Lessions; Ontogeny and Mechanism”
,
Patterson Trust Foundation
,
,
|
|
2002 - 2005
|
Co-PI:Kalajzic, I
Title: “The osteoprogenitor lineage”, Project 1: Analyzing lineage in vitro.
,
NIH-NIDDK U01 Progenitor Cell Genome Anatomy Project
,
,
|
|
2002 - 2004
|
Current grant support:
PI: Kalajzic, I.
Title: “Performance of osteoblasts lineage in the OIM mice”.
,
Children brittle bone foundation
,
,
|
|
1998 - 2000
|
Completed grant support:
PI: Kalajzic, I.
Title: “Retroviral Targeting of the Osteoprogenitor Cells”
,
Osteogenesis Imperfecta Foundation
,
,
|
| Publications |
| Articles |
Ivo
Kalajzic
|
Yang, W. ; Lu, Y. ; Harris, M.A. ; Gluhak-Heinrich, J. ; Bonewald, L.F. : Feng, J.Q. ; Rowe, D.W. ; Harris, S.E.
Identification of An Osteocyte-Specific, Mechanically Regulated Region of the Dentin Matrix Protein 1 promoter
,
ASBMR, ABSTRACT
,
2004
|
Ivo
Kalajzic
|
Suriyapperuma, S.P., Glynn, J., Boucher, N., Kaur, A., Krueger, W. and Rowe, D.W.
Transcriptional Profiling of Murine Marrow Stromal Fibroblast Cultures Treated with Noggin
,
ASBMR, ABSTRACT
,
2004
|
Ivo
Kalajzic
|
Kronenberg, M.S. ; Jiang, X. ; Li, H. ; Pan, L.C. ; Rowe, D.W.
Adipocyte Directed Expression of GFP in Transgenic Mice
,
ASBMR, ABSTRACT
,
2004
|
Ivo
Kalajzic
|
Stahl, A. ; Yang, W. ; Gupta, R. ; Garg, S. ; Achenie, L. ; Feyen, J. ; Rowe, D.W.
Microarray Validation of Osteoblast Lineage Differentiation by GFP Marker Genes
,
ASBMR, ABSTRACT.
,
2004
|
Ivo
Kalajzic
|
Braut, A. ; Guo D. ; Xi, J. ; Kronenberg, M.S. ; Mina, M. ; Harris MA : Harris, S.E. ; Rowe, D.W.
Dentin Matrix Protein 1 Expression During Osteoblastic Differentiation: generation of an osteocyte GFP-transgene
,
Bone.
,
2004
,
35
74-82
|
Ivo
Kalajzic
|
Bilic, I. ; Kronenberg, M.S. ; Jiang, X. ; Rowe, D.W.
Availability of Promoter-GFP Transgenic Mice for Identifying Subpopulations of Cells within the Osteoprogenitor Lineage
,
JBMR, Suppl 1.
,
2003
,
18
S337
|
Ivo
Kalajzic
|
Jiang, X. ; Mack, K. ; Delaney, J. ; D. Rowe, D.W.
Osteoblast Lineage Differentiation Potential in the OIM Mice
,
JBMR, Suppl 1.
,
2003
,
18
S229
|
Ivo
Kalajzic
|
Stahl, A. ; Yang, W. ; Wu, S. ; Johnson, S. ; Feyen, J. ; Rowe, D.W.
Microarray Analysis of Subpopulations of Cells Within Differentiating Murine Osteoblast Cultures
,
JBMR, Suppl 1.
,
2003
,
18
S139
|
Ivo
Kalajzic
|
Stahl, A. ; Yang, W. ; Wu, S. ; Johnson, S. ; Feyen, J. ; Rowe, D.W.
Microarray Analysis of Subpopulations of Cells Within Differentiating Murine Osteoblast Cultures
,
JBMR, Suppl 1.
,
2003
,
18
S139
|
Ivo
Kalajzic
|
Katavic, V. ; Grcevic, D. ; Lukic, I.K. ; Vucenik, V. ; Kovacic, N. ; Marusic, A.
Non-functional Fas ligand increases the formation of cartilage early in the endochondral bone induction by rhBMP-2.
,
Life Sciences.
,
2003
,
74
13-28
|
Ivo
Kalajzic
|
Delany, A.M. ; Bradshaw, A.D. ; Sage, E.H. ; Canalis, E.
Osteonectin-null mutation compromises osteoblasts formation, maturation and survival
,
Endocrinology
,
144
,
2003
,
(6)
2588-2596
|
Ivo
Kalajzic
|
Rajan, T.V. ; Paciorkowski, N. ; Kalajzic, I. ; McGuiness, I.
Ascorbic acid is a requirement for the morphogenesis of the human filarial parasite Brugia malayi
,
J of Parasitology
,
89
,
2003
,
(4)
868-870
|
Ivo
Kalajzic
|
Kalajzic Z. ; Hurley, M.M. ; Lichtler A.C. ; Rowe D.W.
Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin
,
J of Cell Biochem.
,
88
,
2003
,
(6)
1168-1176
|
Ivo
Kalajzic
|
Chung, U. ; Stover, M. ; Rowe, D. W. ; Lichtler. A.C.
Use of a Col1a1-GFP Retroviral Marker System to Monitor In Vitro Differentiation of ES Cells into Osteoblastic Cells
,
JBMR, Suppl 1.
,
2002
,
17
S168
|
Ivo
Kalajzic
|
Erceg, I. ; Marijanovic, I. ; Kronenberg, M.S. ; Tadic, T. ; Lichtler A. C.
Dlx5 Stimulates Osteoblast Differentiation in the Presence of Noggin, an Inhibitor of BMP Signaling
,
JBMR, Suppl 1
,
2002
,
17
S302
|
Ivo
Kalajzic
|
Braut, A. ; Stover, M. ; Narayanan, A. ; George, A. ; Mina M. ; Rowe. D.W.
Analysis of DMP1 Expression During Osteoblast Lineage Differentiation
,
JBMR, Suppl 1.
,
2002
,
17
S247
|
Ivo
Kalajzic
|
Kalajzic, Z. ; Liu, P. ; Du, Z. ; Braut, A. ; Mina, M. ; Canalis, E. ; Rowe, D.W.
Directing the expression of a GFP transgene in differentiated osteoblasts: Comparison between collagen and osteocalcin promoters
,
Bone
,
31
,
2002
6
654-660.
|
Ivo
Kalajzic
|
Terzic, J. , Rumboldt, Z. ; Mack, K. ; Naprta, A. ; Ledgard, F. ; Gronowicz, G. ; Clark, S.H. ; Rowe, D.W.
Osteoblastic Response to the Defective Matrix in the Osteogenesis Imperfecta Murine (OIM) Mouse
,
Endocrinology
,
143 (5) 1594-1601
,
2002
,
(5)
1594-1601
|
Ivo
Kalajzic
|
Braut, A. ; Kalajzic, Z. ; Rowe, D.W. ; Kollar, E.J. ; Mina M.
Col1a1-GFP transgene expression in developing incisors
,
Connect Tissue Res.
,
43
,
2002
,
(2-3)
216-9
|
Ivo
Kalajzic
|
Kalajzic, Z. ; Kaliterna, M. ; Gronowicz, G. ; Clark, S.H. ; Lichtler, A.C. ; Rowe, D.W.
Use of Col1a1GFP transgenes to identify subpopulations of cells at different stages of the osteoblast lineage
,
J Bone Miner Res.
,
2002
,
17
15-25
|
Ivo
Kalajzic
|
Kalajzic, Z. ; Liu, P. ; Du, Z. ; Braut, A. ; Canalis, E. ; Derynck, M. ; Mina M. ; Rowe D.W.
Analysis of an osteocalcin GFP reporter transgene in transgenic mice
,
JBMR, Suppl 1,
,
2001
,
16
S368
|
Ivo
Kalajzic
|
Braut, A. ; Kalajzic, Z. ; Kollar, E.J. ; Rowe, D.W. ; Mina, M.
Expression of the Col1a1 Promoter/Green fluorescent protein transgenes during odontoblast differentiation
,
JBMR, Suppl 1
,
2001
,
16
S442
|
Ivo
Kalajzic
|
Lichtler, A.C., Rowe, D.W.
Isolation and Characterization of Subpopulations of Cells within the Osteoblast Lineage
,
JBMR, Suppl 1
,
2001
,
16
S367
|
Ivo
Kalajzic
|
Primorac D. ; Rowe D.W. ; Mottes M. ; Barisic I. ; Anticevic D. ; Mirandola S. ; Gomez LIra M. ; Kusec V. ; Glorieux FH.
Osteogenesis Imperfecta at the beginning of bone and joint decade
,
Croat. Med. J.
,
42
,
2001
,
(4)
392-414
|
Ivo
Kalajzic
|
Visnjic, D. ; Gronowicz, G., Clark, S.H. ; Lichtler, A.C. ; Rowe, D.W.
Col2.3∆TK transgenic mice: a model for conditional ablation of the osteoblast lineage.
,
J Bone Miner Res.
,
2001
,
16
2222-2232.
|
Ivo
Kalajzic
|
Liu, P ; Stover ML. ; Rowe D.W ; Lichtler A.C.
Human bone marrow stromal cells are efficiently transduced by VSV pseudotyped retrovectors without affecting subsequent osteoblastic differentiation
,
Bone
,
29
,
2001
4
331-335
|
Ivo
Kalajzic
|
Dacic S. ; Visnjic D. ; Lichtler A.C. ; Rowe D.W.
COl1A1 driven transgenic markers of osteoblast lineage progression
,
J Bone Miner Res.
,
2001
,
16
1228-1236
|
Ivo
Kalajzic
|
Stover ML. ; Liu P. ; Rowe D.W. ; Lichtler A.C.
Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells
,
Virology
,
2001
,
284
37-45
|
Ivo
Kalajzic
|
Stover ML. ; Wang CH.L. ; McKinstry M. ; Gronowicz G. ; Clark S.H.; Rowe D.W. ; Lichtler A.C.
Bone directed expression of Col1a1 promoter driven self-inactivating retroviral vector in bone marrow cells and in transgenic mice
,
Molecular Therapy
,
2001
3
543-550
|
Ivo
Kalajzic
|
Kalajzic Z. ; Hurley M.M. ; Rowe D.W.
Stage specific inhibition of osteoprogenitor lineage progression by FGF2 and noggin
,
JBMR, Suppl 1
,
2000
,
15
S216
|
Ivo
Kalajzic
|
Delany A. ; Canalis E.
Aberrant in vitro differentiation of marrow stromal cells from osteonectin-null mice correlates with osteopenic phenotype in vivo
,
JBMR, Suppl 1
,
2000
,
15
S344
|
Ivo
Kalajzic
|
Woitge, H.W. ; Harrison J.R. ; Ivkosic A. ; Clark S.H. ; Krozowski Z. ; Kream B.E.
Loss of glucocorticoid function in osteoblast by targeted overexpression of 11ß-hydroxysteroid dehydrogenase type II
,
JBMR, Suppl 1
,
2000
,
15
S178
|
Ivo
Kalajzic
|
Kalajzic Z. ; Visnjic D. ; Gronowicz G ; Clark S.H. ; Rowe D.W.
A model for observing osteoblast lineage progression in vivo
,
JBMR, Suppl 1.
,
2000
,
15
S196
|
Ivo
Kalajzic
|
Marusic A. ; Grcevic D. ; Katavic V. ; Kovacic N. ; Lukic I.K. ; Lorenzo J.A.
Role of B-lymphocytes in new bone formation
,
Laboratory Investigation
,
2000
,
80
1761-1774
|
Ivo
Kalajzic
|
Niu Q.T. ; Visnjic D. ; Kalajzic Z. ; Clark S.H. ; Yeh J. ; Rowe D.W.
Responsiveness of type I collagen CAT transgene in mice subjected to isometric mechanical loading of bone
,
JBMR, Suppl 1,
,
1999
,
14
S165
|
Ivo
Kalajzic
|
Kaliterna M. ; Mallico E. ; Nahounou M. ; Kalajzic Z. ; Clark S.H. ; Gronowicz G. ; Lichtler A.C. ; Rowe D.W.
Use of Col1a1GFP transgenes to identify osteoblastic lineage
,
JBMR, Suppl 1
,
1999
,
14
S165
|
Ivo
Kalajzic
|
Liu P. ; Stover M.L. ; Rowe D.W. ; Lichtler A.C.
Human bone marrow stromal cell are targeted VSV pseudotyped retrovectors
,
Bone
,
1998
,
23
S616
|
Ivo
Kalajzic
|
Visnjic D. ; Naprta A. ; Gronowicz G. ; Clark S.H. ; Rowe D.W.
Characterization of the Col2.3∆TK transgenic mouse
,
Bone
,
1998
,
23
S181
|
Ivo
Kalajzic
|
Terzic J. ; Mack K. ; Visnjic D. ; Naprta A. , Gronowicz G. ; Clark S.H. ; Rowe D.W.
Osteoblastic activity in the OIM mouse.
,
Bone
,
1998
,
23
S461
|
Ivo
Kalajzic
|
Visnjic D., Liu P., Stover M.L., Hurley M.M., Rowe D.W., Lichtler A.C.
Use of VSV pseudotyped retrovectors to target murine osteoprogenitor cell.
,
Bone 23:S532 1998
,
1998
,
23
S532
|
Ivo
Kalajzic
|
Miric D. ; Rumboldt Z. ; Gancevic I. ; Eterovic D. ; Bozic I. ;Vukovic I.,
Dynamics of platelet aggregation in acute myocardial infarction
,
Lij. Vijesnik
,
1996
,
118
198-201
|
| Serials |
|
Ivo
Kalajzic
|
The Osteoblast Lineage in The OIM Model
,
Conference: New Research Strategies in Osteogenesis Imperfecta
,
Hospital for Special Surgery
,
New York
2003
|
|
Ivo
Kalajzic
|
Rowe D.W.
What have we learned from the murine models of OI? Frontiers in molecular and cellular medicine
,
,
Dubrovnik, Croatia
2001
|
|
Ivo
Kalajzic
|
Woitge, H.W. ; Kronenberg, M.S. ; Clark, S.H. ; Gronowicz, G. ; Lichtler, A. C. ; Kream, B.E.
Development and characterization of Col1a1-Cre transgenic mice for osteoblast directed genomic recombination
,
IBMS-ECT
,
2001
|
|
Ivo
Kalajzic
|
Woitge, H.W. ; Clark, S.H. ; Gronowicz, G. ; Krozowski, Z. ; Harrison, J.R. ; Kream B.E.
Inactivation of glucocorticoids in osteoblasts by targeted overexpression of 11ß-xydroxysteroid dehydrogenase type 2 in transgenic mice
,
IBMS-ECT
,
2001
|
|
Ivo
Kalajzic
|
Rowe, D.W. ; Kalajzic, Z. ; Liu, P. ; Lichtler, A.C.
A strategy of somatic gene therapy for ostegenesis imperfecta, (OI)
,
11th International Congress of Endocrinology, Abstract 9
,
,
Sidney
2000
|
|
Ivo
Kalajzic
|
Woitge HW ; Kronenberg MS ; Kalajzic I ; Clark S ; Lichtler A ; Kream BE.
Development of transgenic mouse lines expressing Col1a1-Cre transgenes as a model for bone-directed gene disruption
,
Z Rheumatol (Suppl.), O63
,
,
(Osteologie 2000 in Würzburg)
2000
|
|
Ivo
Kalajzic
|
Kalajzic Z. , Kaliterna M. ; Rowe D.W.
Use of Col1a1GFP transgenes to identify subpopulation of cells within the osteoblast lineage
,
7th International Conference on osteogenesis imperfecta
,
,
Montreal, Canada
1999
|
|
Ivo
Kalajzic
|
Rowe D.W. ; Lichtler A.C. ; Visnjic D. ; Kalajzic Z. ; Liu P. ; Stover ML.
Steps in developing a strategy of somatic gene therapy for murine OI
,
7th International Conference on osteogenesis Imperfecta
,
,
Montreal, Canada
1999
|
|
Ivo
Kalajzic
|
Terzic J. ; Mack K. ; Visnjic D. ; Naprta A. ; Gronowicz G. ; Clark S.H. ; Rowe D.W.
Osteoblastic activity in the OIM mouse
,
7th International Conference on osteogenesis Imperfecta
,
,
Montreal, Canada
1999
|
|
Ivo
Kalajzic
|
Visnjic D. ; Liu P. ; Stover M.L. ; Rowe D.W. ; Lichtler A.C.
Use of VSV- G pseudotyped retrovectors to target osteoprogenitor cell
,
East Coast Connective Tissue Society Meeting
,
,
Washington DC
1999
|
|
Ivo
Kalajzic
|
Terzic J. ; Mack K. ; Visnjic D. ; Naprta A. ; Gronowicz G. ; Clark S.H. ; Rowe D.W.
Osteoblastic activity in the OIM mouse
,
East Coast Connective Tissue Society Meeting
,
,
Washington DC
1999
|
|
Ivo
Kalajzic
|
Niu Q.T. ; Visnjic D. ; Clark S.H. ; Yeh J. ; Rowe D.W.
Transgenic markers of lineage progression in mechanically loaded bones
,
East Coast Connective Tissue Society Meeting
,
,
Washington DC
1999
|
|
Ivo
Kalajzic
|
Liu P. ; Stover M.L. ; Rowe D.W. ; Lichtler A.C.
Human bone marrow stromal cells targeted by VSV pseudotyped retrovectors maintain their osteoblastic phenotype
,
East Coast Connective Tissue Society Meeting
,
,
Washington DC
1999
|
|
Ivo
Kalajzic
|
Visnjic D. ; Naprta A. ; Gronowicz G. ; Clark S.H. ; Rowe D.W.
Conditional ablation of osteoblast lineage cells in Col2.3∆TK trangenic mice
,
East Coast Connective Tissue Society Meeting
,
,
Washington DC,
1999
|
|
Ivo
Kalajzic
|
Terzic J. ; Mack K. ; Visnjic D. ; Naprta A. ; Gronowicz G. ; Clark S.H. ; Yeh J. ; Rowe D.W.
Transgenic markers of lineage progression in mechanically loaded bones
,
Proceedings. First Biennial Space Biomedical Investigators Workshop
,
,
League City, Texas
1999
,
214
|
|
Ivo
Kalajzic
|
Tadic T. ; Kaliterna M. ; Kronenberg M.S. ; Lichtler A.C.
Use of replication competent avian retroviral vectors to express proteins in mouse osteoblastic cells
,
East Coast Connective Tissue Society Meeting
,
,
Philadelphia
1998
|
|
Ivo
Kalajzic
|
Liu P. ; Stover M.L. ; Visnjic D. ; Rowe D.W. ; Lichtler A.C.
Use of VSV pseudotyped retrovectors to target marrow stromal cells
,
East Coast Connective Tissue Society Meeting
,
,
Philadelphia
1998
|
|
Ivo
Kalajzic
|
Braut, A. ; Kalajzic Z. ; Rowe, D.W. ; Kollar E.J. ; M. Mina
Transgenic Mice Expressing the Col1a1-tagged Green Fluorescent Protein in Odontoblasts
,
TMD (June 16-21, 2001)
,
2001
,
LYON, FRANCE
0
|
| Awards |
|
1999
|
Outstanding presentation award,
East Coast Connective Tissue Society Meeting, Washington DC,
,
Washington
,
United States
|
|
2000
|
Michael Geisman Fellowship Award
(Osteogenesis Imperfecta Foundation)
,
,
|
|
2001
|
ASBMR “John Haddad Young Investigator Award”,
,
|
|
2002
|
Children Brittle Bone Fellowship Award
,
|
| AMAC |
|
|
----
|
| Memberships All |
|
:: :: - :: ::
|
member
,
American Society for Bone and Mineral Research,
,
,
|
| Pool |
|
|
YES
|
| Cooperation |
|
|
Znanstvena suradnja;Suradnja sa gospodarstvom;
|
| Expertise |
Basic Research in Bone Biology
Mechanisms and treatments approaches for osteoporosis Osteogenesis Imperfecta Vascular calcification in atherosclerosis
My research is focused on addressing the questions related to osteoblast lineage differentiation in the states of pathological disorders of bone (osteoporosis and osteogenesis imperfecta), and in the field of ectopic calcification (vascular calcification). I am currently analyzing the performance of osteoblast lineage in the murine model of osteogenesis imperfecta using the promoter-transgene (green fluorescent protein-GFP) approach to address the questions of differentiation of osteoblast lineage, Recently, I have begun to develop the GFP-lineage based concept to identify the origins of a cell that gives rise to the cells with osteoblastic phenotype (calcifying vascular cells) during the process of vascular calcifications, an as yet undefined population of cells which reside in the arterial vessel wall have the ability to differentiate into cells with the characteristics proper to a mature and functional osteoblast.
|
|